Rigel Pharmaceuticals | RIGL - Capitaux D'Emprunt

Prix De L'Action
29.55
Variation Quotidienne
0.35 1.18%
Mensuellement
11.28%
Annuel
71.67%
Q2 Prévisions
28.40




Capitaux D'Emprunt Changement Date
Agenus USD 169.66M 146.06M 2025-12
Amgen USD 50B 2.43B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
MacroGenics USD 70M 256K 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Veracyte USD 0 0 2025-03